Notably, both classic vitiligo and drug-induced VLD share key immunologic features, including IFN-γ/CXCL10-mediated chemotaxis and the involvement of tissue-resident memory T cells and melanocyte-specific CD8+ T cells. The gene discussed is CD8A; the disease is vitiligo.